This information collection request
covers the reporting and recordkeeping provisions associated with
FDA's implementation of sections 222, 223, and 224 of the Food and
Drug Administration Amendments Act of 2007 (FDAAA), which require
that device establishment registrations and listings under section
21 U.S.C. 360(p) (including the submission of updated information)
be submitted to the Secretary by electronic means, unless the
Secretary grants a request for waiver of the requirement because
the use of electronic means is not reasonable for the person
requesting the waiver.
There has been an adjustment in
the burden hours and annual responses for this collection. FDA
attributes the increase in burden to the additional information
that must be submitted to comply with FDAAA. FDA attributes the
decrease in responses to more accurate estimates. Prior to the
electronic system, registrants were not deleted from they rolls
unless an FDA District Office confirmed that the registrant was no
longer in business. Under the system currently in place, potential
registrants were notified that they must confirm their
registrations or they would be deleted from the system.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.